Get notified when PURR files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts

Red Flags Detected

  • Large Warrant Overhang With Exercise Prices Below Current Trading Price (new) — One-third of the 27.4M warrants (9.1M shares) are exercisable at $9.375, well below the $11.56 current price, creating immediate dilution risk.
  • Going Concern (unchanged) — Sonnet BioTherapeutics disclosed substantial doubt about ability to continue as going concern due to recurring losses, negative cash flows since inception, and cash of $5.1M at September 30, 2025 expected to fund operations only into February 2026.
  • Cryptocurrency Treasury Strategy (unchanged) — Filing discloses a named Bitcoin treasury/financing strategy (1940-Act risk). On minimal cash with going-concern doubt, this non-standard treasury pivot is material.
NASDAQ: PURR Hyperliquid Strategies Inc 424B3

Hyperliquid Strategies (PURR) registers 35.2M shares for resale by Rorschach Advisors LLC

Filed August 27, 2026 · ~1 min read

Key Changes

  • high

    This is a resale registration, not a primary offering. Rorschach Advisors LLC may sell up to 7.8M issued shares plus 27.4M shares underlying warrants. The company receives no proceeds; all proceeds go to the selling securityholder.

    The Offering view on EDGAR →
  • medium

    The 27.4M warrants have five-year terms and three exercise price tranches: one-third at $9.375, one-third at $12.50, and one-third at $18.75. The warrants were issued December 2, 2025.

    The Offering view on EDGAR →
  • medium

    PURR stock traded at $11.56 on August 26, 2026, making the lowest-priced warrant tranche ($9.375) in-the-money while the two higher tranches remain out-of-the-money.

    The Offering view on EDGAR →

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (IREN 10-K) is open in full — no account needed.

Partner

Trade PURR commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?
View original filing on SEC.gov

Figures/quotes linked to EDGAR · Narrative written by AI · Aug 28, 2026 · How we verify